Acadian Asset Management
TTOO

Acadian Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Acadian Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,537
Closed -$67K – 1901
2023
Q2 		$67K Buy
+9,537
New +$220K ﹤0.01% 1483

Other funds holding TTOO

BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Acadian Asset Management's TTOO Position: Q3 2023 in Review

Acadian Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q3 2023, closing a stake of 9,537 shares — an estimated $67K sold.

Acadian Asset Management first reported a position in TTOO in Q2 2023 and held it in 1 quarter. The position peaked at $67K in Q2 2023. 40 funds tracked by Wall St. Rank hold TTOO as of Q3 2023.

  • Acadian Asset Management reported no remaining T2 Biosystems, Inc position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 9,537 T2 Biosystems, Inc shares in Q3 2023, an estimated $67K.
  • Acadian Asset Management first reported a position in T2 Biosystems, Inc in Q2 2023 and held it in 1 quarter.
  • Acadian Asset Management's T2 Biosystems, Inc position peaked at $67K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.